If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 221 - 230 of 299
A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 12 Years and Older With APOL1-mediated Proteinuric Kidney Disease
Objective
VX-147 in APOL1- Mediated Proteinuric Kidney Disease
Protocol No
NEPH-VERTEX-VX21-147-301
Categories
Neurally Decoding Imagined Language in Severe Expressive Aphasia
Objective
Neurally Decoding Imagined Language in Severe Expressive Aphasia
Protocol No
NEURO-IIT-ANDERSON-DIL
Behavioral Assessment of Semantic Representation Data
Objective
Behavioral Assessment of Semantic Representation Data
Protocol No
NEURO-IIT-LF-BASR
A Randomized Clinical Trial of tDCS to Remediate Phonological Impairment in Aphasia
Objective
HD-tDCS for Phonological Impairment in Aphasia
Protocol No
NEURO-IIT-PILLAY-ALF-TDCS
Behavioral Aphasia Treatments
Objective
Behavioral Aphasia Treatments
Protocol No
NEURO-IIT-PSB-BAT
Categories
TES To Remediate Phonological Impairments After Stroke
Objective
TES for Language Impairment
Protocol No
NEURO-IIT-SHAH-TES
Categories
Gut-oral-microbiota-brain Axis in Adults at Risk for AD
Objective
SCD Microbiome Project
Protocol No
NEURO-IIT-UMFLEET-SCDMICROB
Statin Use in Intracerebral Hemorrhage Patients
Objective
Statins In Intracerbral Hemorrhage (SATURN)
Protocol No
NEURO-NINDS-SATURN
Categories
Parkinson's Foundation PD GENEration Genetic Registry
Objective
Parkinson's Foundation PD GENEration Genetic Registry
Protocol No
NEURO-PF-PDGENE
A Phase II Study of Tailored Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early-Stage Endometrial Cancer (RAINBO BLUE & TAPER)
Objective
Tailoring Therapy in Post-surgical Patients With Low-risk Endometrial Cancer
Protocol No
NRG-GY032
Categories